Cognitive deficits and delayed neuronal loss in a mouse model of multiple microinfarcts

Minghuan Wang1, Jeffrey J Iliff, Yonghong Liao

  • 1Division of Glial Disease and Therapeutics, Center for Translational Neuromedicine, Department of Neurosurgery, University of Rochester Medical Center, Rochester, New York 14642, USA.

Insights

This study introduces a mouse model for brain microinfarcts, revealing delayed neuronal death and demyelination. These findings suggest a broader therapeutic window for microinfarcts compared to larger strokes.

Area of Science:

  • Neurology
  • Neuroscience
  • Pathology

Background:

  • Microinfarcts are common in aging brains, linked to cognitive decline and dementia.
  • The natural history and progression of microinfarcts are not well understood.
  • Existing research often focuses on larger stroke models, leaving microinfarcts understudied.

Purpose of the Study:

  • To establish a mouse model for studying diffuse microinfarcts.
  • To investigate the temporal progression of microinfarcts, including gliosis, neuronal loss, and demyelination.
  • To compare the pathological course of microinfarcts to larger cerebral infarcts.

Main Methods:

  • Induction of multiple diffuse microinfarcts in C57BL/6J mice via unilateral internal carotid artery injection of cholesterol crystals.
  • Histological analysis using markers for microglia (CD68), reactive astrocytes (GFAP), and myelin.
  • Assessment of neuronal cell death and aquaporin 4 mislocalization over time post-stroke.

Main Results:

  • Microinfarcts were characterized by microglial/macrophage cores and reactive astrogliosis.
  • Persistent reactive gliosis and aquaporin 4 mislocalization were observed for up to 1 month.
  • Neuronal cell death progressed gradually, reaching 60% by 28 days post-stroke.
  • Delayed demyelination was evident starting 28 days after the induced microinfarcts.

Conclusions:

  • Microinfarct development follows a distinct timeline compared to larger infarcts.
  • The observed delayed neuronal loss and demyelination suggest a potentially wider therapeutic window for microinfarcts.
  • This mouse model provides a valuable tool for exploring microinfarct pathology and therapeutic strategies.

Related Concept Videos